Fig. 2: Prognostic implications of TP53 mutations in t-MDS and p-MDS. | Blood Cancer Journal

Fig. 2: Prognostic implications of TP53 mutations in t-MDS and p-MDS.

From: Molecular characteristics and clinical implications of TP53 mutations in therapy-related myelodysplastic syndromes

Fig. 2

A, B Kaplan–Meier survival curves of OS in t-MDS and p-MDS patients stratified by TP53mut VAF. C, D Kaplan–Meier survival curves of OS in t-MDS and p-MDS patients stratified by TP53 allelic status. E Kaplan–Meier survival curves of OS in t-MDS patients stratified by TP53 mutations and CK. F Kaplan–Meier survival curves of OS in TP53mut patients stratified by t-MDS and p-MDS. t-MDS therapy-related myelodysplastic syndromes, p-MDS primary myelodysplastic syndromes, OS overall survival, TP53mut TP53-mutated, VAF variant allele frequency, CK complex karyotype.

Back to article page